- Filed
- Mar 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 4, 2025 | 93.62M sh |
| Cash And Equivalents | Q3 2025 · Jan 25, 2025 | $149.22M |
| Cash And Equivalents | Q3 2025 · Apr 27, 2024 | $327.05M |
| Current Liabilities | Q3 2025 · Jan 25, 2025 | $119.61M |
| Current Liabilities | Q3 2025 · Apr 27, 2024 | $137.93M |
| Total Liabilities | Q3 2025 · Jan 25, 2025 | $193.78M |
| Total Liabilities | Q3 2025 · Apr 27, 2024 | $210.64M |
| Current Assets | Q3 2025 · Jan 25, 2025 | $352.57M |
| Current Assets | Q3 2025 · Apr 27, 2024 | $536.87M |
| Total Assets | Q3 2025 · Jan 25, 2025 | $594.02M |
| Total Assets | Q3 2025 · Apr 27, 2024 | $770.15M |
| Stockholders Equity | Q3 2025 · Apr 27, 2024 | $559.51M |
| Stockholders Equity | Q3 2025 · Jan 27, 2024 | $510.22M |
| Shares Diluted | Q3 2025 · Jan 27, 2024 | 93.64M sh |
| Shares Diluted | Q3 2025 · Jan 27, 2024 | 93.62M sh |
| Dividends Paid | Q3 2025 · Jan 27, 2024 | $0 |
| Capex | Q3 2025 · Jan 27, 2024 | $19.46M |
| Operating Cash Flow | Q3 2025 · Jan 27, 2024 | $137.47M |
| Eps Diluted restated | Q3 2025 · Jan 27, 2024 | $0.42 |
| Eps Diluted | Q3 2025 · Jan 27, 2024 | $1.42 |
| Eps Basic restated | Q3 2025 · Jan 27, 2024 | $0.42 |
| Eps Basic | Q3 2025 · Jan 27, 2024 | $1.42 |
| Sga Expense | Q3 2025 · Jan 27, 2024 | $48.85M |
| Sga Expense | Q3 2025 · Jan 27, 2024 | $153.79M |
| Net Income | Q3 2025 · Jan 27, 2024 | $39.59M |
| Net Income | Q3 2025 · Jan 27, 2024 | $133.01M |
| Operating Income | Q3 2025 · Jan 27, 2024 | $48.18M |
| Operating Income | Q3 2025 · Jan 27, 2024 | $165.59M |
| Gross Profit | Q3 2025 · Jan 27, 2024 | $97.03M |
| Gross Profit | Q3 2025 · Jan 27, 2024 | $319.37M |
| Cost Of Revenue | Q3 2025 · Jan 27, 2024 | $173.03M |
| Cost Of Revenue | Q3 2025 · Jan 27, 2024 | $575.01M |
| Revenue | Q3 2025 · Jan 27, 2024 | $270.07M |
| Revenue | Q3 2025 · Jan 27, 2024 | $894.38M |